IT1296914B1 - Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera - Google Patents

Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera

Info

Publication number
IT1296914B1
IT1296914B1 IT97MI002663A ITMI972663A IT1296914B1 IT 1296914 B1 IT1296914 B1 IT 1296914B1 IT 97MI002663 A IT97MI002663 A IT 97MI002663A IT MI972663 A ITMI972663 A IT MI972663A IT 1296914 B1 IT1296914 B1 IT 1296914B1
Authority
IT
Italy
Prior art keywords
overcoming
barrier
pharmaceutical composition
composition including
water
Prior art date
Application number
IT97MI002663A
Other languages
English (en)
Inventor
Maria Rosa Gasco
Original Assignee
Maria Rosa Gasco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Rosa Gasco filed Critical Maria Rosa Gasco
Priority to IT97MI002663A priority Critical patent/IT1296914B1/it
Priority to AT98965704T priority patent/ATE303799T1/de
Priority to ES98965704T priority patent/ES2247736T3/es
Priority to AU21551/99A priority patent/AU2155199A/en
Priority to PCT/EP1998/007664 priority patent/WO1999027918A1/en
Priority to DE69831511T priority patent/DE69831511T2/de
Priority to EP98965704A priority patent/EP1071408B1/en
Priority to US09/555,828 priority patent/US6419949B1/en
Publication of ITMI972663A1 publication Critical patent/ITMI972663A1/it
Application granted granted Critical
Publication of IT1296914B1 publication Critical patent/IT1296914B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT97MI002663A 1997-12-01 1997-12-01 Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera IT1296914B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT97MI002663A IT1296914B1 (it) 1997-12-01 1997-12-01 Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
AT98965704T ATE303799T1 (de) 1997-12-01 1998-11-27 Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke
ES98965704T ES2247736T3 (es) 1997-12-01 1998-11-27 Microparticulas para el transporte de sustancias farmaceuticas a traves de la mucosa y la barrera hematoencefalica.
AU21551/99A AU2155199A (en) 1997-12-01 1998-11-27 Microparticles for drug delivery across mucosa and the blood-brain barrier
PCT/EP1998/007664 WO1999027918A1 (en) 1997-12-01 1998-11-27 Microparticles for drug delivery across mucosa and the blood-brain barrier
DE69831511T DE69831511T2 (de) 1997-12-01 1998-11-27 Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke
EP98965704A EP1071408B1 (en) 1997-12-01 1998-11-27 Microparticles for drug delivery across mucosa and the blood-brain barrier
US09/555,828 US6419949B1 (en) 1997-12-01 1998-11-27 Microparticles for drug delivery across mucosa and the blood-brain barrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI002663A IT1296914B1 (it) 1997-12-01 1997-12-01 Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera

Publications (2)

Publication Number Publication Date
ITMI972663A1 ITMI972663A1 (it) 1999-06-01
IT1296914B1 true IT1296914B1 (it) 1999-08-03

Family

ID=11378297

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI002663A IT1296914B1 (it) 1997-12-01 1997-12-01 Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera

Country Status (8)

Country Link
US (1) US6419949B1 (it)
EP (1) EP1071408B1 (it)
AT (1) ATE303799T1 (it)
AU (1) AU2155199A (it)
DE (1) DE69831511T2 (it)
ES (1) ES2247736T3 (it)
IT (1) IT1296914B1 (it)
WO (1) WO1999027918A1 (it)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296914B1 (it) 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
US7153525B1 (en) 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
AU784191B2 (en) * 2000-04-11 2006-02-16 Ibergesfer, S.L. Structure for a washbasin
ATE374603T1 (de) * 2000-12-27 2007-10-15 Ares Trading Sa Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation
US7763663B2 (en) 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
ES2411656T3 (es) * 2002-03-13 2013-07-08 Thomas SKÖLD Sistemas de administración a base de agua
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
EP1513853A2 (en) * 2002-05-24 2005-03-16 Neopharm, Inc. Cardiolipin compositions, methods of preparation and use
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
ITMI20022323A1 (it) * 2002-10-31 2004-05-01 Maria Rosa Gasco Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
US20050101605A1 (en) * 2003-11-07 2005-05-12 Ahmed Salah U. Oral liquid formulations of methotrexate
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
WO2006097793A2 (en) * 2004-04-15 2006-09-21 Chiasma, Ltd. Compositions capable of facilitating penetration across a biological barrier
ITMI20041151A1 (it) * 2004-06-09 2004-09-09 Maria Rosa Gasco Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
US20090180964A1 (en) * 2005-06-24 2009-07-16 Rao Papineni Transmucosal delivery of optical, spect, multimodal,drug or biological cargo laden nanoparticle(s) in small animals or humans
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US20070154403A1 (en) * 2006-01-05 2007-07-05 Thomas Skold Oral, Pulmonary and Transmucosal Delivery Composition
US7914988B1 (en) 2006-03-31 2011-03-29 Illumina, Inc. Gene expression profiles to predict relapse of prostate cancer
EP1867323A1 (en) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmaceutical compositions with biological barriers permeation enhancing properties
EP2157911A2 (en) * 2007-05-16 2010-03-03 Yeda Research And Development Co. Ltd. Assessment of blood-brain barrier disruption
EP2249817B8 (en) * 2008-02-18 2012-03-21 Csir Nanoparticle carriers for drug administration and process for producing same
EP2123262A1 (en) 2008-05-20 2009-11-25 Consorzio per il Centro di Biomedica Moleculare Scrl Polyelectrolyte-encapsulated gold nanoparticles capable of crossing blood-brain barrier
WO2010009291A1 (en) * 2008-07-16 2010-01-21 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles containing bioactive peptides
WO2010032140A2 (en) * 2008-09-17 2010-03-25 Chiasma Inc. Pharmaceutical compositions and related methods of delivery
WO2011021175A2 (en) 2009-08-18 2011-02-24 Ben Gurion University Of The Negev Research And Development Authority System and method for analyzing imaging data
US10275680B2 (en) 2011-10-19 2019-04-30 Tel Hashomer Medical Research Infrastructure And Services Ltd. Magnetic resonance maps for analyzing tissue
EP2645099A1 (en) * 2012-03-30 2013-10-02 Phares Pharmaceutical Research N.V. Biorelevant compositions
JP6526627B2 (ja) 2013-04-24 2019-06-05 テル ハショメール メディカル リサーチ インフラストラクチャー アンド サービシズ リミテッド 組織解析用の磁気共鳴マップ
JP6091721B2 (ja) * 2014-12-19 2017-03-08 積水化学工業株式会社 製剤
WO2016118281A1 (en) 2015-01-20 2016-07-28 TetraDerm Group LLC Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
EP3253401A4 (en) 2015-02-03 2018-11-21 Chiasma Inc. Method of treating diseases
CN117731591A (zh) 2016-11-21 2024-03-22 艾里奥治疗公司 大试剂的透皮递送
CN113271925B (zh) * 2019-01-07 2023-11-10 釜山大学校产学协力团 使用w/o/w型三油酸甘油酯乳液促进血脑屏障开放的药物递送平台
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
DE4131562A1 (de) * 1991-09-18 1993-03-25 Medac Klinische Spezialpraep Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln)
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
IT1292142B1 (it) * 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
IT1296914B1 (it) 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera

Also Published As

Publication number Publication date
EP1071408A1 (en) 2001-01-31
ATE303799T1 (de) 2005-09-15
EP1071408B1 (en) 2005-09-07
DE69831511T2 (de) 2006-06-14
ITMI972663A1 (it) 1999-06-01
ES2247736T3 (es) 2006-03-01
WO1999027918A1 (en) 1999-06-10
AU2155199A (en) 1999-06-16
US6419949B1 (en) 2002-07-16
DE69831511D1 (de) 2005-10-13

Similar Documents

Publication Publication Date Title
IT1296914B1 (it) Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
AR020288A1 (es) Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado.
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
ES2187201T3 (es) Empleo de esteroles y de esterolesteres a nanoescala.
FR2779962B1 (fr) Composition cosmetique ou dermopharmaceutique sous forme de perles et procedes pour la preparation
BR0100424A (pt) Nanoemulsão óleo-em-água que contém lipìdios anfìfilos e um polìmero não iÈnico, composição cosmética de uso tópico, suas utilizações, processo de tratamento não terapêutico e processo para espessar as nanoemulsões óleo-em -água
ATE281844T1 (de) Orale verabreichung von nukleinsäure-impstoffen durch partikelkomplexe
CA2330330A1 (en) Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
ES2178187T3 (es) Sistema finamente dispersos de tipo agua en aceite sin emulsionantes.
AR018252A1 (es) Forma de dosificacion farmaceutica en particulas solidas adecuada para suministro oral.
BR0100335A (pt) Nanoemulsão óleo-em-água à base de lipìdios anfìfilos e de polìmeros catiÈnicos, composição cosmética de uso tópico, utilizações, processo de tratamento não-terapêutico e processo para espessar as nanoemulsões óleo-em-água
BR0100652A (pt) Sistema hidráulico
ES2145158T3 (es) Nueva formulacion de emulsion.
AR030862A1 (es) Formulaciones medicinales en aerosol
CO5611097A2 (es) Tableta farmaceutica
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
WO2001005362A3 (de) Emulgatorfreie feindisperse systeme vom typ wasser-in-öl
WO1998005300A3 (en) Delivery system for pharmaceutical agents encapsulated with oils
ES2231176T3 (es) Uso de beta-(1,3)-glucanos nanometricos hidrosolubles.
ATE331528T1 (de) Präparationen, die virus-ähnliche partikel als immunpotentiatoren enthalten und durch die schleimhaut verabreicht werden.
FR2788980B1 (fr) Nanoemulsion a base d'alkenyl succinates alkoxyles ou d'alkenyl succinates de glucose alkoxyles, et ses utilisations dans les domaines cosmetique, dermatologique, ophtalmologique et/ou pharmaceutique
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
ATE332140T1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
FR2817257B1 (fr) Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant

Legal Events

Date Code Title Description
0001 Granted